Fillable Silence Therapeutics Announces Positive Response by USPTO that ...

Description
Silence Therapeutics Announces Positive Response by USPTO that Affirms Validity of Four Foundational RNAi Patents USPTO issues notice of intent to issue reexamination certificates associated with patents covering innovative "Zamore Design Rules" licensed by Silence from the University of Massachusetts Medical School London, December 12, 2011 Silence Therapeutics plc (AIM: SLN) ("Silence" or the...
Fill & Sign Online, Print, Email, Fax, or Download
  • Fill Online
  • eSign
  • eFax
  • Email
  • Add Annotations
  • Share
Fill & Sign Online, Print, Email, Fax, or Download
Fill Online